Professor of Medicine
Nephrology
Dr. Jonathan Himmelfarb, MD
Jonathan Himmelfarb is an expert in the field of Nephrology. He went to medical school at George Washington University School of Medicine. George Washington University School of Medicine has a rank of 67 in research and a 0 in primary care He over the years received 2 awards: "Regional Top Doctor" and "Fellow (ASNF)". Jonathan Himmelfarb has written publications. He has 38 publications published with PubMed. The lastest publication is: 'Association of Vascular Access Type with Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis.'
Publications
- Rapid and sensitive analysis of reduced and oxidized coenzyme Q10 in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and application t...
- Functional Comparison of Human Colonic Carcinoma Cell Lines and Primary Small Intestinal Epithelial Cells for Investigations of Intestinal Drug Permeability and First-...
- Association of Vascular Access Type With Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis.
- Maintenance Dialysis throughout the World in Years 1990 and 2010.
- Border Health: State-Level Variation in Predialysis Nephrology Care.
- Dietary Acid Load Is Associated With Serum Bicarbonate but not Insulin Sensitivity in Chronic Kidney Disease.
- A Quantitative Approach to Screen for Nephrotoxic Compounds In Vitro.
- Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis.
- Creatinine Clearance, Walking Speed, and Muscle Atrophy: A Cohort Study.
- Changes in symptom burden and physical performance with initiation of dialysis in patients with chronic Kidney disease.
- Self-Rated Health and Adverse Events in CKD.
- Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients.
- A Pilot Randomized Crossover Trial Assessing the Safety and Short-Term Effects of Pomegranate Supplementation in Hemodialysis Patients.
- Estimated GFR and Circulating 24,25-Dihydroxyvitamin D3 Concentration: A Participant-Level Analysis of 5 Cohort Studies and Clinical Trials.
- Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in Acute renal disease (PICARD).
- Dialysis Therapies: A National Dialogue.
- Acute kidney injury is associated with increased hospital mortality after stroke.
- Characteristics and Performance of Minority-Serving Dialysis Facilities.
- Provision of Antioxidant Therapy in Hemodialysis (PATH): A Randomized Clinical Trial.
- Tooth Loss Strongly Associates With Malnutrition in Chronic Kidney Disease.
- New Therapies for Diabetic Kidney Disease.
- Effects of chronic Kidney disease and uremia on hepatic drug metabolism and transport.
- Initiation of Dialysis Should be Timely: Neither Early Nor Late.
- Adverse effects of systemic glucose absorption With peritoneal dialysis: how good is the evidence?
- Prevention and treatment of protein energy wasting in chronic Kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabo...
- Association between Physical Performance and All-Cause Mortality in CKD.
- Kidney disease and increased mortality risk in type 2 diabetes.
- Dialysis in 2012: Could longer and more frequent haemodialysis improve outcomes?
- Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic Kidney disease.
- Tragic options and compromised care: undocumented immigrants With ESRD.
- A Prospective Study of Frailty in Nephrology-Referred Patients With CKD.
- Periodontitis associated with chronic Kidney disease among Mexican Americans.
- Assessment of Physical Activity in Chronic Kidney Disease.
- The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic Kidney disease.
- Biomarkers of Endothelial Activation Are Associated With Poor Outcome in Critical Illness.
- Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress.
- Urinary excretion of RAS, BMP, and WNT pathway components in diabetic Kidney disease.
Schools
George Washington University School Of Medicine
Maine Med Center
Brigham and Women39s Hospital
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Amyloidosis
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Regional Top Doctor
- Fellow (ASNF)
Education
-
Brigham and Women's Hospital -
Maine Medical Center -
George Washington University School of Medicine
Hospital
-
UW Medicine/Harborview Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275533903 |
| Last Name Of The Provider | HIMMELFARB |
| First Name Of The Provider | JONATHAN |
| View All |
Similar Doctors
|
Dr. Michael C. Akom, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Avinash Ghimire, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fahima Nasreen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ioan Cosma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa Y. Yeung, MD |
|
|
Dr. Fernando A. Lopez Osma, MD |
|
|
Dr. Gary Diperna, DO |
|
|
Dr. Namita Singh, MD |